Full Text View
Tabular View
No Study Results Posted
Related Studies
Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection (QT-Hp)
This study has been completed.
Study NCT00520949   Information provided by Aga Khan University
First Received: August 24, 2007   Last Updated: April 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Treatment of Helicobacter Pylori
Interventions listed in this trial
Augmentin (Amoxicillin-clavulanic)
Furoxone (furazolidone)
Esso (esomeprazole)
Additional drug interventions recognized in this trial
Amoxicillin
Bismuth
Bismuth tripotassium dicitrate
Furazolidone
Omeprazole
More general drug interventions related to this trial
Antacids
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Infective Agents, Local
Anti-Infective Agents, Urinary
Anti-Ulcer Agents
Antiparasitic Agents
Antiprotozoal Agents
Antitrichomonal Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Monoamine Oxidase Inhibitors
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Sponsors listed in this trial
Aga Khan University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services